
Hypertriglyceridemia: new approaches in management and treatment
Author(s) -
Anna Wolska,
Yang Zhihong,
Alan T. Remaley
Publication year - 2020
Publication title -
current opinion in lipidology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.412
H-Index - 124
eISSN - 1473-6535
pISSN - 0957-9672
DOI - 10.1097/mol.0000000000000710
Subject(s) - hypertriglyceridemia , dyslipidemia , medicine , intensive care medicine , acute pancreatitis , pancreatitis , atherosclerotic cardiovascular disease , disease , cholesterol , triglyceride
Hypertriglyceridemia (HTG), a form of dyslipidemia characterized by elevated plasma of triglycerides (TG), is associated with an increased risk for acute pancreatitis. Moreover, HTG has recently been shown to be linked to the development of atherosclerotic cardiovascular disease (ASCVD); therefore, there is a great interest in better understanding the pathophysiology of HTG and improving its clinical management. In this review, we briefly describe TG metabolism, recent guidelines for the clinical management of HTG and provide an overview of the current and potential new therapies for HTG.